Ads
related to: mrna
Search results
The Global Blood Supply May Be Massively Contaminated
Mercola· 2 hours agoIn a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 3 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
US, European nations consider vaccinating workers exposed to bird flu
Reuters via Yahoo News· 2 hours agoThe United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 5 days agoA replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation. About mRNA-4157 (V940) mRNA-4157 (V940) is ...
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA...
WTRF Wheeling· 4 days agoProvidence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development ...
Researchers develop mRNA vaccine for strain of avian flu | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 2 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing increasing scrutiny by public health officials. The Penn team is using ...
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 4 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 20 hours agoAdditionally, LNPs are now being investigated as carriers for a range of therapeutics, offering a...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 20 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
From 'loser' to laureate: Nobel winner's advice to young scientists
Nature· 1 day ago“10 years ago, I was considered a loser,” she says. Advice she offers is to follow the work of your...